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ABSTRACT
Objective: Previous studies suggested that slow injection of propofol may increase the
hypnotic effect during induction of anesthesia. The aim of the present study was therefore to
investigate whether injection rate of propofol has an influence on its maximum effect.
Design: Randomized, single-blind trial.
Setting: This study has been carried out in the operating rooms of a university hospital. An
anesthesiologist and a resident performed the study with the aid of changing nursing staff.
Participants: We investigated 99 unpremedicated patients aged 18 to 60 years with American
Society of Anesthesiologists (ASA) physical status 1–3.
Interventions: Anesthesia was induced by intravenous injection of propofol (2 mg/kg).
Propofol was manually injected in group 1 over a period of 5 s; in group 2 (120-s injection
interval), and in group 3 (240-s injection interval), propofol was administered by an injection
pump. After loss of consciousness, mask ventilation was performed with 100% oxygen.
Bispectral index (BIS) was used to measure the hypnotic effect of propofol. After the decrease
of BIS to the minimum value (i.e., maximum hypnotic effect) and the following increase of BIS
to 60, the study period was finished and anesthesia was performed according to clinical criteria.
Outcome Measures: We analyzed whether injection speed has an influence on the
maximum hypnotic effect of a given dose of propofol (2 mg/kg).
Results: BISmin marks the maximum electroencephalogram (EEG) effect of the propofol bolus
as measured by the BIS. The lowest mean BISmin was measured in group 1 (28.7 6 10.3). In
group 2, BISmin was 33.0 (613.9), and in group 3, BISmin was 36.4 (611.0). There were no
significant differences between group 2 and groups 1 or 3, but there were significant
differences between groups 1 and 3. In group 1, BISmin was reached after 102.91 s (644.20), in
group 2 after 172.33 s (629.76), and in group 3 after 274.21 s (645.40). These differences were
statistically significant for all comparisons. In summary, the lowest value for BISmin was achieved
in the group with the fastest rate of propofol injection (group1, 5 s). The highest BISmin was
obtained in the group with the slowest rate of injection (group 3, 240 s). The hemodynamic
parameters were not significantly different among groups.
Conclusions: The hypnotic peak effect of propofol is lower with extremely slow injection (240
s versus 5 s). For clinically usual injection rates (5 s and 120 s), there was no significant
difference in propofol peak effect.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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PLoS CLINICAL TRIALSINTRODUCTION
The clinical daily routine indicates that slowing the rate of
administration of propofol can lead to a reduction of up to
50% in the dose of propofol required to achieve the onset of
a clinical endpoint of anesthesia (i.e., loss of consciousness
[LOC]) when titrating to effect. Therefore, it has been
concluded that a slow injection requires a smaller dose of
propofol as the graded effect is weakened by fast injection
[1,2]. This conclusion contradicts the pharmacologic consid-
eration that a fast injection would lead to a higher peak
concentration, and, in consequence, to a higher peak effect in
the brain.
The present study was designed to measure the electro-
encephalogram (EEG) peak effect of a propofol bolus (2 mg/
kg) injected with different infusion rates.
Although it is known that propofol has cardiovascular
effects, the inﬂuence of injection rate on these cardiovascular
changes is less clear. Gillies and Lees [3] found that faster
injection rates of propofol caused greater reductions in blood
pressure (BP). Other similar studies did not show differences
in BP for different injection rates [4]. An additional aim of
this study was therefore to investigate the inﬂuence of
different injection rates on hemodynamic parameters.
METHODS
Participants
We investigated 99 patients, of both sexes, from 18 to 60 years
old with American Society of Anesthesiologists (ASA) physical
status 1–3. All patients were scheduled for elective surgery
under general anesthesia. Exclusion criteria were emergency
surgery, obesity (Broca index . 25%), indication for rapid
sequence induction, administration of drugs that affect the
central nervous system, a history of alcohol or drug abuse,
neurological or psychiatric diseases, or contraindications
against the use of propofol. The study was carried out in the
anesthesia induction rooms of the operating theatre. An
anesthesiologist and a resident performed the study with the
aid of changing nursing staff.
Interventions
Having approval from the university’s ethics committee, and
after written informed consent was obtained, this prospec-
tive, single-blind study was performed for 99 patients. No
premedication was given prior to induction.
Baseline heart rate (HR) and BP were measured within 72 h
before surgery and immediately before induction of anes-
thesia. An intravenous catheter was inserted into the brachial
vein and infusion of lactated Ringer’s solution was started.
Anesthesia was induced by intravenous injection of the
propofol bolus (2 mg/kg). In group 1, propofol (propofol
Abbott 1%) was manually injected over a period of 5 s; in
group 2 (120-s injection interval) and group 3 (240-s injection
interval), propofol was administered by an injection pump.
When spontaneous respiration ceased, patients were venti-
lated by face mask with 100% O2. The following clinical
information was recorded: LOC and loss of lash reﬂex (LOL).
LOC was deﬁned as the time when the patient stopped
responding to commands (‘‘squeeze my hand’’). After the
maximum hypnotic effect of propofol, a decrease of the
hypnotic component of anesthesia was indicated by an
increase of BIS. As soon as BIS was increased to index values
of 55–60, the investigation was completed and additional
propofol, opioid, and muscle relaxant were given. The
patients’ tracheas were intubated and anesthesia was con-
tinued according to standard clinical practice.
Patients were attached to a 3-lead electrocardiogram, pulse
oxymeter, and BP cuff (Datex AS/3 Compact Monitor).
Additionally, a two-channel fronto-temporal EEG (Aspect
A-1000, Aspect Medical Systems, Newton, Massachusetts,
United States) was measured. EEG electrodes were positioned
according to the manufacturer’s recommendations at AT1,
AT2, Fpz (common reference), F1 (ground). The high pass was
set to 0.5 Hz; no low pass was used. After attaching the
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Editorial Commentary
Background: Propofol is an injectable compound that is commonly
used to bring about anesthesia in adults and in children aged more than
three years. The rate at which propofol is injected is thought to affect the
total dose of the drug that’s needed to achieve loss of consciousness and
lowered blood pressure during anesthesia. Previous trials have looked at
the effect of different injection rates on anesthesia (time taken to lose
consciousness, and degree of consciousness). In this trial of 99 patients
scheduled for elective surgery, the researchers studied the effect of three
different propofol injection rates. Patients were randomized to receive
propofol injected over 5 s, 120 s, or 240 s. In each group the total dose of
propofol (per kilogram of a patient’s bodyweight) was the same. The
main measure used to assess anesthetic effect was the bispectral index.
This is a method of translating information from an electroencephalo-
gram (graph showing electrical activity in the brain) into a standard
measurement that reflects the patient’s level of consciousness. The
researchers also recorded time to loss of consciousness, i.e., when
patients stopped responding to commands, and took blood pressure
measurements.
What this trial shows: The researchers found that anesthetic effect, as
measured using the bispectral index, was greatest in the patients who
had received the fastest injections as compared with those who had
received slower injections. However, the difference was only significant
when comparing the fastest injection (5 seconds) with the slowest (240
seconds). In addition, the time taken to achieve anesthesia (as measured
using the bispectral index), and time to loss of consciousness (as
indicated by no response to commands), were lowest in patients who
had the fastest injections; these differences were also significant. The
researchers did not find an effect of the different injection rates on
maximum and minimum blood pressure during the trial.
Strengths and limitations: The trial recruited enough patients to
properly assess whether patients receiving different injection rates
would have different responses to anesthesia. A limitation, acknowl-
edged by the authors, is that the bispectral index uses a commercial
computer program to interpret electroencephalograms and to produce a
number value for anesthetic effect. Some evidence suggests that the
output of the computer program may not correlate precisely with level
of consciousness, and as the algorithm is not public, any irregularities in
the way it works cannot be discovered by researchers outside the
company. It is also of note that the slowest injection rate used by the
researchers, 240 seconds, is not normally used in clinical practice.
Contribution to the evidence: The results of this study support those
from a few other small randomized trials that faster injections of
propofol achieve a larger anesthetic effect, and more quickly. However,
the effect of injection rate on blood pressure is less clear; this study does
not show any differences in the effect of injection rate on blood
pressure, but other randomized trials have found an association.
The Editorial Commentary is written by PLoS staff, based on the reports of the
academic editors and peer reviewers.electrocardiogram, BP cuff, and pulse oxymeter, EEG electro-
des were attached and impedance was checked and main-
tained below 1.5 kX. Digital EEG and calculated EEG
parameters were recorded continuously. BP and HR were
measured every minute. Data were stored on a PC (Data-
logger Software, Aspect Medical Systems).
Objectives
The primary goal of the study was to investigate whether
faster injection rates of propofol lead to an increased
maximum effect as measured by BIS. Secondary criteria were
differences in onset times and differences in hemodynamic
parameters.
Outcomes
The main parameter investigated in this study was the
maximum hypnotic effect as indicated by the minimum BIS
value (BISmin). In addition, the times until LOC (t-LOC), LOL
(t-LOL), and BISmin (t-BISmin) were measured. Furthermore,
we analyzed BIS at LOC (BIS-LOC), BIS at LOL (BIS-LOL),
and BIS 30 s after LOC (BIS-LOC
þ30s). The minimum and
maximum differences to baseline in HR (HRmin,H R max),
mean arterial pressure (MAPmin, MAPmax), and systolic and
diastolic BP (BP
SYS
min,B P
DIA
min,B P
SYS
max,B P
DIA
max) were
calculated.
Sample Size
With a sample size between 13 and 33 patients per group, a
one-factor ANOVA reaches 80% power and a signiﬁcance
level of 5% to detect a difference in mean values which is
characterized by a variance of mean values, V ¼ R(l l)
2/3, in
the range of 20.5 to 55.5. A standard deviation of 14.00 is the
basis of this calculation. The ranges described were derived
by simulations on the basis of BIS data measured during
induction of anesthesia (mean BIS 36, standard deviation 14).
Minimum requirement was the detection of a difference of
mean values in the range of one standard deviation (14.00). As
a consequence of the imprecision of the underlying assump-
tions, a blind interim analysis was performed after n ¼ 20
patients per group. Results of this analysis were not made
available to anybody involved in the clinical study. On the
basis of this analysis, the sample size was corrected to the
maximum of 33 per group.
Randomization—Sequence Generation
Blocked randomization was performed. The randomization
list was generated as follows: the ﬁrst block consisted of 60
patients (three groups with 20 patients, reﬂecting three
different injection rates), allowing a blind interim analysis at
this point. The second block consisted of an additional 39
patients, 13 in each of the three groups. For each block, a
Microsoft Excel table was generated with the corresponding
groups in column 1. In column 2, a number was added using
the ‘‘random number’’ function of Microsoft Excel. Next, the
tables were sorted by values in column 2 (in ascending order),
which rearranged the group assignments according to the
randomly generated numbers.
Randomization—Implementation
According to the computer-generated list, envelopes with
group assignments were sealed and arranged in the order of
the randomization list. This order was maintained during
patient enrollment.
Randomization—Allocation Concealment
After written informed consent had been obtained, the
patients were randomly assigned to one of the three different
injection rates as the responsible anesthesiologist opened the
next envelope.
Blinding
Only patients were blind to the different injection rates.
Statistical Methods
Blind interim analysis of BISmin values did not reveal
signiﬁcant differences between groups. For all 99 patients,
dataanalysiswasperformed.ANOVAandsubsequentposthoc
tests with Bonferroni correction (p , 0.05) were performed to
identify differences in BISmin values between groups. In an
exploratory approach, times from injection start to LOC and
BISmin also were analyzed. A Kruskal-Wallis test and ANOVA
were performed to detect differences in demographic values
between groups. Data are presented as mean 6 SD.
RESULTS
Participant Flow
In the present study, all patients who were asked agreed to
take part in the trial. We assume that the reason for this high
enrollment rate is the fact that consent to the study did not
result in a major deviation from standard clinical practice
and did not cause additional risk for the patients. In fact, the
additional EEG monitoring may have added safety for the
patients.
All patients received the treatment as allocated, no patient
was excluded, and no deviations from the study protocol
occurred (see Figure 1, the CONSORT ﬂowchart).
Recruitment
The patients were recruited from March to December 2003.
All the patients were selected and included in the study
within 72 h before surgery.
Baseline Data
Table 1 shows demographic data of the patients. There were
no signiﬁcant differences among the three groups (Table 1).
Numbers Analyzed
All 99 patients who underwent random allocation were
analyzed according to group assignment, no patient was
excluded from the analysis.
Outcomes and Estimation
Maximum effect: BISmin. BISmin marks the maximum EEG
effect of the propofol bolus as measured by the EEG
bispectral index (BIS). ANOVA revealed a statistically
signiﬁcant difference in BISmin between groups (p , 0.05).
The lowest mean BISmin was measured in group 1 (28.7 6
10.3). In group 2, BISmin was 33.0 (613.9), and in group 3,
BISmin was 36.4 (611.0). This difference was statistically
signiﬁcant only between groups 1 and 3, whereas BISmin of
group 2 showed no signiﬁcant difference from either of the
other two groups (Table 2). Figure 2 shows the mean BIS
curve progression for each of the three groups.
Time from start of injection to maximum effect BISmin. In
group 1, t-BISmin was reached after 102.91 s (644.20), in
group 2 after 172.33 s (629.76), and in group 3 after 274.21 s
www.plosclinicaltrials.org July | 2006 | e17 0003
Propofol Injection Rate and Peak Effect(645.40). These differences were statistically signiﬁcant for all
comparisons (Table 3).
Time from end of injection to maximum effect—adjusted t-
BISmin. As a consequence of the decreasing bolus rate, there is
an increasing time delay before the total amount of propofol
is given. Therefore, t-BISmin* was calculated: the duration of
injection (5 s, 120 s, 240 s) was subtracted from t-BISmin.B y
this approach, the time to BISmin after injection of the total
dose of propofol was calculated. t-BISmin* was 99.85 s
(647.87) in group 1, 52.41 s (630.23) in group 2, and 32.69
s( 643.77) in group 3.
t-LOC and t-LOL. t-LOC was deﬁned as the time from the
beginning of the propofol injection to LOC. t-LOC in group
1 was 35.76 s (620.62), in group 2 108.18 s (617.98), and in
group 3 177.73 s (643.82). t-LOC increased in every group by
approximately 70 s (p , 0.05).
t-LOL was deﬁned as the time from the beginning of
propofol injection to loss of eyelash reﬂex. t-LOL is clinically
used as a sign of deeper anesthesia and occurs after t-LOC. t-
Figure 1. The CONSORT Flowchart Illustrates Patient Enrollment, Allocation, Follow-Up, and Analysis
DOI: 10.1371/journal.pctr.0010017.g001
.......................................................................................................................................................................................
Table 1. Demographic Data of the Patients (n ¼ 99)
Group Age (Years) Weight (kg) Height (cm) Sex (Female/Male) ASA Physical Status 1/2
Group 1 43.30 6 13.32 75.61 6 14.27 173.06 6 9.50 12/21 19/14
Group 2 38.216 11.84 72.58 6 12.66 173.52 6 8.79 14/19 21/10
Group 3 41.85 6 12.46 74.09 6 13.47 171.71 6 9.08 14/19 18/17
There were no significant differences between the three groups in age, weight, height, sex, or ASA physical status.
Data are presented as mean 6 SD. The number of patients in each group was 33.
DOI: 10.1371/journal.pctr.0010017.t001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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(620.31), and 210.45 s (6 44.95) in group 3 (p , 0.05).
BIS-values at LOC and LOL. BIS-LOC in group 1 was 91.3
(68.0), in group 2 75.7 (610.4), and in group 3 66.8 (614.1).
BIS at the time of LOL was 74.8 (625.1) in group 1, 55.7
(619.0) in group 2, and 51.8 (615.2) in group 3. For both,
BIS-LOC and BIS-LOL values in group 1 (5 s) were
signiﬁcantly higher than in group 2 (120 s) or group 3 (240
s). There were no signiﬁcant differences between group 2 and
group 3.
BIS-values 30 seconds after LOC. BIS-LOC
þ30s is the BIS
value 30 seconds after LOC. BIS-LOC
þ30s was 49.1 (625.2) in
group 1, 49.9 (619.9) in group 2, and 50.7 (614.6) in group 3.
There were no signiﬁcant differences in BIS-LOC
þ30s between
the three groups.
Hemodynamic parameters. Baseline hemodynamic values
(HR, MAP, BP
SYS, and BP
DIA) were calculated from the mean
values measured 72 h before surgery and before induction of
anesthesia. Baseline hemodynamic measurements did not
show signiﬁcant differences between the groups (Table 4).
The maximum and minimum values of hemodynamic
parameters from the beginning of propofol injection to the
end of the investigation were identiﬁed. These minima and
maxima did not show signiﬁcant differences between groups
(Tables 5 and 6).
Adverse Events
During induction of anesthesia, surgery, and at the recovery
room no side effects were observed, neither in groups 1 and 2,
nor in group 3.
DISCUSSION
Interpretation
The study shows an inﬂuence of propofol injection rate on its
maximum effect as measured by EEG BIS. After extremely
slow induction of anesthesia (240 s), the propofol peak effect
is signiﬁcantly lower than after rapid injection (5 s), as
indicated by higher BIS values. The EEG was used to
determine the effect of different rates of propofol infusion.
A possible limitation of the study design is the use of BIS as an
endpoint. The correlation between propofol concentrations
and BIS values may not be entirely linear. In particular,
increasing concentrations of anesthetics may be misinter-
preted as a lighter level of hypnosis [5]. During propofol
anesthesia, this phenomenon was observed at the onset of
burst suppression [6]. It is known that in the range of 20–30, a
‘‘plateau’’ in the BIS algorithm exists. The BIS will only
decrease if a burst suppression ratio higher than 40 appears.
As the BIS algorithm is proprietary, one can only speculate
about the reasons for this nonlinearity. The use of a
proprietary algorithm induces additional (unknown) sources
of error. Therefore, the use of proprietary ‘‘depth of
anesthesia’’ indices has recently been criticized, and it has
been suggested that such monitors not be used until the
algorithms have been revealed [7]. In the current study,
however, we accepted the limitation. In particular, it has been
shown that BIS correlates with propofol target concentra-
tions [8,9]. Therefore, we decided to use BIS as a measure of
propofol peak effect despite its known limitations. As
indicated by differences in BISmin, rapid injection (5 s) of
propofol has a higher peak effect than very slow injection
(240 s). The sample size of the study was designed to detect a
Figure 2. Mean BIS Developing for Each of the Three Groups
The figure shows the sharp BIS decrease and the fast reaching of BISmin in
group 1. In contrast to group 1, in group 3 the BIS curve runs very flat and it
takes a longer time to reach BISmin.
DOI: 10.1371/journal.pctr.0010017.g002
.......................................................................................
Table 3. t-BISmin
Group t-BISmin (seconds)
Group 1 102.91 6 44.20*
Group 2 172.33 6 29.76
Group 3 274.21 6 45.40**
Data are presented as mean 6 SD.
*Significant difference from group 2 (p , 0.05).
**Significant difference from group 1.
DOI: 10.1371/journal.pctr.0010017.t003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.......................................................................................
Table 2. The Maximum BIS Effect (BISmin)
Group BISmin
Group 1 28.7 6 10.3
Group 2 33.0 6 13.9
Group 3 36.4 6 11.0*
BISmin marks the maximum BIS effect of the propofol bolus. Data are presented as
mean 6 SD.
*Significant difference from group 1 (p , 0.05).
DOI: 10.1371/journal.pctr.0010017.t002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.......................................................................................
Table 4. Baseline Hemodynamic Values
Group HR
(Beats/min)
MAP
(mmHg)
BP
SYS
(mmHg)
BP
DIA
(mmHg)
Group 1 71.41 6 10.09 94.98 6 6.53 130.33 6 10.79 75.91 6 6.48
Group 2 69.76 6 10.27 93.65 6 8.25 128.15 6 11.86 74.97 6 7.29
Group 3 71.23 6 11.50 93.42 6 9.64 131.12 6 17.53 72.76 6 6.65
Baseline hemodynamic values did not show significant differences between the
groups. Data are presented as mean 6 SD.
DOI: 10.1371/journal.pctr.0010017.t004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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difference of 15 or more in BIS values. Therefore, a smaller
difference between 5-s and 120-s or between 120-s and 240-s
injection rates can not be excluded.
The faster the injection rate, the faster speciﬁc effects
(LOC, LOL, maximum peak effect) were reached. As the
analysis of t-BISmin* and the time from end of injection to
BISmin shows, the injection rate is an intrinsic part of these
results.
Generalizability
In the present study, hemodynamic parameters were stable in
all groups. This is consistent with previous studies mentioned
above [1,2]. In two groups of patients (18–50 y/60 y, ASA
physical status 1–2), the effect of different injection rates (25
mg/min, 50 mg/min, 100 mg/min, 200 mg/min, bolus) on
propofol effect were studied. There were no signiﬁcant
differences in HR, BP
SYS,o rB P
DIA [2]. A study in younger
patients (18–55 y, injection rates 50 mg/min, 100 mg/min, 200
mg/min) also did not show signiﬁcant changes in BP [1]. In
contrast, a study in elderly patients (.60 y, ASA physical
status 1–4) found signiﬁcantly less decrease in BP with slow
injection of propofol [10]. In contrast to this study, and
similar to the above-mentioned studies, elderly patients and
patients with preexisting diseases were not included in our
study. This, and the volume preload of lactated Ringer’s
solution, may explain why none of our patients showed
hemodynamic instability.
The greater effect of quickly injected propofol is consistent
with pharmacokinetic principles: fast injection rate increases
peak concentration, which will subsequently lead to an
increased drug peak effect. This is supported by studies that
indicate an increased effect site concentration after fast
injection. In an animal study with sheep, catheters were
inserted into the carotid artery, sinus sagittalis, and the right
atrium. A propofol bolus (100 mg) was administered with
different injection rates (200 mg/min, 50 mg/min, 20 mg/min).
The peak concentration of propofol was found to increase
with faster injection [11]. In concordance with these ﬁndings,
results of the present study indicate a decreased propofol
peak effect with slow injection of propofol.
Overall Evidence
Previous studies showed that the duration of injection has an
inﬂuence on the total dose of propofol that is necessary for
LOC. In 1992, Peacock et al. showed that rapid injection of
propofol (200 mg/min) leads to signiﬁcantly faster LOC when
compared with a slow injection (25 mg/min) [2]. Even more
interesting, the propofol dose required to induce LOC was
signiﬁcantly lower in patients who received the slow
injection. Results of this study were consistent with previous
studies in adult [1] and elderly patients [10]. Therefore, the
authors concluded that the necessary dose of propofol for
induction of anesthesia is lower when the duration of
injection is longer. This seems to contradict our results and
the described pharmacokinetic principles. This difference
can be explained by the different endpoints used in the
clinical studies. LOC, as used in previous studies, is an all-or-
none phenomenon that reﬂects a threshold at the wider scale
of hypnotic effects. As a consequence, an ‘‘overshoot’’ effect,
i.e., a ‘‘deeper’’ hypnotic level, will not be detected when
LOC is used as the endpoint. If propofol is injected until
LOC, different doses may result from different injection
rates. This is due to pharmacokinetic and pharmacodynamic
properties of the drug. After injection, propofol is distrib-
uted in the plasma and is transferred to the effect site, i.e.,
the brain. The propofol fraction in the plasma is referred to
as ‘‘drug in transit.’’ In previous studies, a constant rate of
propofol was given until LOC occurred. LOC, however,
reﬂects the effect of propofol at the effect site, i.e., in the
brain, whereas the total dose of propofol given includes the
propofol ‘‘in transit,’’ i.e., in the plasma. After termination of
propofol injection at LOC, the total amount of propofol that
has been injected is transferred to the brain, and sub-
sequently the hypnotic level will increase after LOC (over-
shoot reaction). With a constant transit time to the effect
site, faster injection rates will lead to higher doses of
propofol in transit, i.e., a higher total dose of propofol. This
may explain why propofol injection until LOC as an
endpoint will result in propofol doses that increase with
increasing injection rates. In summary, a slow injection of
propofol leads to improved titration when administered to
clinical effect, whereas the peak effect of a given dose seems
higher after rapid injection.
SUPPORTING INFORMATION
CONSORT Checklist
Found at DOI: 10.1371/journal.pctr.0010017.sd001 (48 KB DOC).
Trial Protocol
Found at DOI: 10.1371/journal.pctr.0010017.sd002 (57 KB DOC).
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Table 5. The Maximum Values of Hemodynamic Parameters
Group HRmax
(Beats/min)
MAPmax
(mmHg)
BP
SYS
max
(mmHg)
BP
DIA
max
(mmHg)
Group 1 82.55 6 10.21 100.67 6 10.28 136.61 6 16.99 79.73 6 8.69
Group 2 78.91 6 12.65 100.55 6 10.65 134.70 6 15.40 79.49 6 8.44
Group 3 78.79 6 13.17 102.79 6 12.96 142.52 6 26.16 79.00 6 9.71
The maximum parameters did not show significant differences between the groups.
Data are presented as mean 6 SD.
DOI: 10.1371/journal.pctr.0010017.t005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.......................................................................................
Table 6. The Minimum Values of Hemodynamic Parameters
Group HRmin
(Beats/min)
MAPmin
(mmHg)
BP
SYS
min
(mmHg)
BP
DIA
min
(mmHg)
Group 1 66.73 6 8.69 78.54 6 9.32 108.15 6 10.77 62.18 6 8.03
Group 2 64.18 6 11.89 78.33 6 11.08 108.73 6 12.04 60.36 6 10.43
Group 3 63.18 6 11.43 78.47 6 11.62 111.55 6 21.63 60.06 6 8.20
The minimum parameters did not show significant differences between the groups.
Data are presented as 6 SD.
DOI: 10.1371/journal.pctr.0010017.t006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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